News
Revenue: US$4.40b (down 42% from FY 2024). Net loss: US$2.70m (down by 100% from US$1.91b profit in FY 2024). US$0.005 loss per share (down from US$3.52 profit in FY 2024). AI is about to change ...
StockStory.org on MSN2d
Microchip Technology, Marvell Technology, onsemi, Amplitude, and Genesco Shares Are Soaring, What You Need To KnowWhat Happened? A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +2 ...
Analysts have provided Marvell Tech with 21 ratings, resulting in a consensus rating of Buy. The average one-year price ...
amidst a favorable trend for technology... Review Microchip Tech's (MCHP) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future ...
Microchip Technology Incorporated develops, manufactures, and sells smart, connected, and secure embedded control solutions in the Americas, Europe, and Asia. The company offers general purpose 8 ...
Microchip Technology Incorporated develops, manufactures, and sells smart, connected, and secure embedded control solutions in the Americas, Europe, and Asia. The company offers general purpose 8 ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Having recently appointed a new chief executive, Raffi Stepanian, the medical technology company is building real sales ...
It's unsurprising that Covid-19 has served both as an agent and an accelerant in driving significant trends in healthcare revenue cycle management (RCM). What we see is a mixed bag of regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results